Cargando…

Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study

Background: Bronchiectasis exacerbations are often treated with prolonged antibiotic use, even though there is limited evidence for this approach. We therefore aimed to investigate the baseline clinical and microbiological findings associated with long courses of antibiotic treatment in exacerbated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scioscia, Giulia, Amaro, Rosanel, Alcaraz-Serrano, Victoria, Gabarrús, Albert, Oscanoa, Patricia, Fernandez, Laia, Menendez, Rosario, Mendez, Raul, Foschino Barbaro, Maria Pia, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912316/ https://www.ncbi.nlm.nih.gov/pubmed/31726739 http://dx.doi.org/10.3390/jcm8111950

Ejemplares similares

Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year
por: Alcaraz-Serrano, Victoria, et al.
Publicado: (2021)

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
por: Menéndez, Rosario, et al.
Publicado: (2020)

Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis
por: Cabrera, Roberto, et al.
Publicado: (2022)

Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
por: Menéndez, Rosario, et al.
Publicado: (2017)

Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations
por: Rosales-Mayor, Edmundo, et al.
Publicado: (2017)

Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
por: Menéndez, Rosario, et al.
Publicado: (2017)

Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
por: Carpagnano, Giovanna E, et al.
Publicado: (2019)

Exacerbation of Bronchiectasis
por: Polverino, Eva, et al.
Publicado: (2017)

The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases
por: Fernández-Barat, Laia, et al.
Publicado: (2023)

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
por: Campisi, Raffaele, et al.
Publicado: (2023)

Chest pain and exacerbations of bronchiectasis
por: King, Paul T, et al.
Publicado: (2012)

The Effects of Bronchiectasis on Asthma Exacerbation
por: Kang, Hye Ran, et al.
Publicado: (2014)

Exacerbations in COPD Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2017)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Exacerbation Prevention and Management of Bronchiectasis
por: Choi, Joon Young
Publicado: (2023)

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
por: Lacedonia, Donato, et al.
Publicado: (2017)

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Erratum: The Effects of Bronchiectasis on Asthma Exacerbation
por: Kang, Hye Ran, et al.
Publicado: (2014)

Respiratory Viruses in Acute Exacerbations of Bronchiectasis
por: Park, Yea Eun, et al.
Publicado: (2021)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Shorter and Longer Courses of Antibiotics for Common Infections and the Association With Reductions of Infection-Related Complications Including Hospital Admissions
por: Palin, Victoria, et al.
Publicado: (2021)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020)

Influence of Pseudomonas Aeruginosa on Exacerbation in Patients with Bronchiectasis
por: Chawla, Kiran, et al.
Publicado: (2015)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
por: Gupta, Shruti, et al.
Publicado: (2022)

Denominator of Cranial Vault Asymmetry Index: Choosing Between Longer and Shorter Diagonal Lengths
por: Miyabayashi, Hiroshi, et al.
Publicado: (2023)

MicroRNA expression profile during different conditions of hypoxia
por: Lacedonia, Donato, et al.
Publicado: (2018)

Real life experience of molnupiravir as a treatment of SARS-CoV-2 infection in vaccinated and unvaccinated patients: a letter on its effectiveness at preventing hospitalization
por: Scioscia, Giulia, et al.
Publicado: (2022)

Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future
por: Moriondo, Giorgia, et al.
Publicado: (2022)

The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis
por: Shih, Vivian H., et al.
Publicado: (2023)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

Exacerbation of bronchiectasis by Pseudomonas monteilii: a case report
por: Aditi, et al.
Publicado: (2017)

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis
por: Liu, Yang, et al.
Publicado: (2021)

The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations
por: Gao, Yong-hua, et al.
Publicado: (2023)

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fke5vagvkej3ln825akis423ec